# Tumor neuroectodérmico primitivo

> Página oficial: https://raras.org/doenca/tumor-neuroectodermico-primitivo
> Fonte: Raras.org — Banco de Dados de Doenças Raras em Português (CC BY-NC-SA 4.0)
> Última atualização: 2026-05-07

## Identificadores

- **ORPHA**: 251870 — https://www.orpha.net/en/disease/detail/251870

## Descrição clínica

A rare Ewing sarcoma/peripheral primitive neuroectodermal tumor that affects the central nervous system either as a primary dural neoplasm or by direct extension from adjacent soft tissues or bone.

## Epidemiologia e herança

- **Prevalência**: <1 / 1 000 000
- **Padrão de herança**: Not applicable

## Ensaios clínicos ativos (1)

- **NCT07087002** [RECRUITING]: GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults — https://clinicaltrials.gov/study/NCT07087002
- **NCT03434262** [COMPLETED]: SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors — https://clinicaltrials.gov/study/NCT03434262
- **NCT02095132** [COMPLETED]: Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors — https://clinicaltrials.gov/study/NCT02095132
- **NCT00788125** [TERMINATED]: Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors — https://clinicaltrials.gov/study/NCT00788125
- **NCT00983398** [UNKNOWN]: Melphalan, Carboplatin, Mannitol, and Sodium Thiosulfate in Treating Patients With Recurrent or Progressive CNS Embryonal or Germ Cell Tumors — https://clinicaltrials.gov/study/NCT00983398
- **NCT01346267** [COMPLETED]: Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy — https://clinicaltrials.gov/study/NCT01346267
- **NCT00047320** [COMPLETED]: Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors — https://clinicaltrials.gov/study/NCT00047320
- **NCT00238173** [TERMINATED]: Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors — https://clinicaltrials.gov/study/NCT00238173
- **NCT01158300** [COMPLETED]: PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors — https://clinicaltrials.gov/study/NCT01158300
- **NCT01088763** [TERMINATED]: Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia — https://clinicaltrials.gov/study/NCT01088763

## Importante

O Raras **não diagnostica e não prescreve**. Esta página é educativa e informativa.
Pacientes devem consultar profissionais de saúde qualificados para decisões clínicas.

---

**Citação sugerida**: Raras.org — Tumor neuroectodérmico primitivo. Disponível em: https://raras.org/doenca/tumor-neuroectodermico-primitivo
**Formato HTML**: https://raras.org/doenca/tumor-neuroectodermico-primitivo
**Formato RDF/Turtle**: https://raras.org/api/rdf?orpha=251870